0.00
price down icon2.94%   -0.102
 
loading

Neximmune Inc Azioni (NEXI) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
48.63%
2.7575
5.3678 9.9958 7.7847 9.8254
Operating Income/Loss
48.63%
-2.7575
-5.3678 -9.9958 -7.7847 -9.8254
Nonoperating Income/Loss
3,591%
-0.3198
0.00916 0.1416 0.2182 0.2603
Income/Loss From Continuing Operations Before Tax
720.05%
-3.0773
-0.3753 -9.8542 -7.5665 -9.5651
Income Tax Expense/Benefit
100.00%
-
4.9834 - - -
Income/Loss From Continuing Operations After Tax
42.57%
-3.0773
-5.3586 -9.8542 -7.5665 -9.5651
Net Income/Loss
42.57%
-3.0773
-5.3586 -9.8542 -7.5665 -9.5651
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
26,310%
1.2505
0.00474 1.0479 26.08 26.08
Diluted Average Shares
26,310%
1.2505
0.00474 1.0479 26.08 26.08
Basic Earnings Per Share
50.70%
-2.46
-4.99 -9.40 -0.29 -0.37
Diluted Earnings Per Share
50.70%
-2.46
-4.99 -9.40 -0.29 -0.37
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$20.52
price down icon 1.06%
$35.91
price down icon 0.64%
$21.27
price up icon 1.67%
$104.85
price down icon 0.99%
$104.80
price down icon 0.28%
biotechnology ONC
$267.12
price up icon 0.12%
Capitalizzazione:     |  Volume (24 ore):